These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 18231572)

  • 1. Differential expression of receptor tyrosine kinases (RTKs) and IGF-I pathway activation in human uterine leiomyomas.
    Yu L; Saile K; Swartz CD; He H; Zheng X; Kissling GE; Di X; Lucas S; Robboy SJ; Dixon D
    Mol Med; 2008; 14(5-6):264-75. PubMed ID: 18231572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical localization of growth factors and their receptors in uterine leiomyomas and matched myometrium.
    Dixon D; He H; Haseman JK
    Environ Health Perspect; 2000 Oct; 108 Suppl 5():795-802. PubMed ID: 11035985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased insulin sensitivity in IGF-I receptor--deficient brown adipocytes.
    Mur C; Valverde AM; Kahn CR; Benito M
    Diabetes; 2002 Mar; 51(3):743-54. PubMed ID: 11872675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tamoxifen interferes with the insulin-like growth factor I receptor (IGF-IR) signaling pathway in breast cancer cells.
    Guvakova MA; Surmacz E
    Cancer Res; 1997 Jul; 57(13):2606-10. PubMed ID: 9205064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-like growth factor I synergizes with interleukin 4 for hematopoietic cell proliferation independent of insulin receptor substrate expression.
    Soon L; Flechner L; Gutkind JS; Wang LH; Baserga R; Pierce JH; Li W
    Mol Cell Biol; 1999 May; 19(5):3816-28. PubMed ID: 10207105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of ErbB2 receptor inhibits IGF-I-induced Shc-MAPK signaling pathway in breast cancer cells.
    Lu Y; Zi X; Zhao Y; Pollak M
    Biochem Biophys Res Commun; 2004 Jan; 313(3):709-15. PubMed ID: 14697248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of insulin receptor substrate-1 and Shc on insulin-like growth factor I receptor signaling in early passages of cultured human fibroblasts.
    Takahashi Y; Tobe K; Kadowaki H; Katsumata D; Fukushima Y; Yazaki Y; Akanuma Y; Kadowaki T
    Endocrinology; 1997 Feb; 138(2):741-50. PubMed ID: 9003010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of SHPS-1 in the regulation of insulin-like growth factor I-stimulated Shc and mitogen-activated protein kinase activation in vascular smooth muscle cells.
    Ling Y; Maile LA; Lieskovska J; Badley-Clarke J; Clemmons DR
    Mol Biol Cell; 2005 Jul; 16(7):3353-64. PubMed ID: 15888547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen-induced changes in IGF-I, Myb family and MAP kinase pathway genes in human uterine leiomyoma and normal uterine smooth muscle cell lines.
    Swartz CD; Afshari CA; Yu L; Hall KE; Dixon D
    Mol Hum Reprod; 2005 Jun; 11(6):441-50. PubMed ID: 15879465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p66shc negatively regulates insulin-like growth factor I signal transduction via inhibition of p52shc binding to Src homology 2 domain-containing protein tyrosine phosphatase substrate-1 leading to impaired growth factor receptor-bound protein-2 membrane recruitment.
    Xi G; Shen X; Clemmons DR
    Mol Endocrinol; 2008 Sep; 22(9):2162-75. PubMed ID: 18606861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysregulation of IGF-I signaling in uterine leiomyoma.
    Burroughs KD; Howe SR; Okubo Y; Fuchs-Young R; LeRoith D; Walker CL
    J Endocrinol; 2002 Jan; 172(1):83-93. PubMed ID: 11786376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transactivation of the EGF receptor mediates IGF-1-stimulated shc phosphorylation and ERK1/2 activation in COS-7 cells.
    Roudabush FL; Pierce KL; Maudsley S; Khan KD; Luttrell LM
    J Biol Chem; 2000 Jul; 275(29):22583-9. PubMed ID: 10807918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired Shc, Ras, and MAPK activation but normal Akt activation in FL5.12 cells expressing an insulin-like growth factor I receptor mutated at tyrosines 1250 and 1251.
    Leahy M; Lyons A; Krause D; O'Connor R
    J Biol Chem; 2004 Apr; 279(18):18306-13. PubMed ID: 14963047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Receptor tyrosine kinases and their hormonal regulation in uterine leiomyoma.
    Yu L; Moore AB; Dixon D
    Semin Reprod Med; 2010 May; 28(3):250-9. PubMed ID: 20414848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence that basal activity, but not transactivation, of the epidermal growth factor receptor tyrosine kinase is required for insulin-like growth factor I-induced activation of extracellular signal-regulated kinase in oral carcinoma cells.
    Kuribayashi A; Kataoka K; Kurabayashi T; Miura M
    Endocrinology; 2004 Nov; 145(11):4976-84. PubMed ID: 15271882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-like growth factor-I-dependent signal transduction pathways leading to the induction of cell growth and differentiation of human neuroblastoma cell line SH-SY5Y: the roles of MAP kinase pathway and PI 3-kinase pathway.
    Kurihara S; Hakuno F; Takahashi S
    Endocr J; 2000 Dec; 47(6):739-51. PubMed ID: 11228049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tyrosine phosphorylation-dependent and -independent role of Shc in the regulation of IGF-1-induced mitogenesis and glycogen synthesis.
    Sasaoka T; Ishiki M; Wada T; Hori H; Hirai H; Haruta T; Ishihara H; Kobayashi M
    Endocrinology; 2001 Dec; 142(12):5226-35. PubMed ID: 11713219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The reciprocal regulation of gamma-synuclein and IGF-I receptor expression creates a circuit that modulates IGF-I signaling.
    Li M; Yin Y; Hua H; Sun X; Luo T; Wang J; Jiang Y
    J Biol Chem; 2010 Oct; 285(40):30480-8. PubMed ID: 20670935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin growth factor-I and epidermal growth factor receptors recruit distinct upstream signaling molecules to enhance AKT activation in mammary epithelial cells.
    Fleming JM; Desury G; Polanco TA; Cohick WS
    Endocrinology; 2006 Dec; 147(12):6027-35. PubMed ID: 16990343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential regulation of insulin receptor substrate-2 and mitogen-activated protein kinase tyrosine phosphorylation by phosphatidylinositol 3-kinase inhibitors in SH-SY5Y human neuroblastoma cells.
    Kim B; Leventhal PS; White MF; Feldman EL
    Endocrinology; 1998 Dec; 139(12):4881-9. PubMed ID: 9832424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.